Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | ATM | Q13315 | 2/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 7/20 | 0.47 |
| ▸ | LMNA | P02545 | 6/20 | 0.47 |
| ▸ | HPGD | P15428 | 6/20 | 0.47 |
| ▸ | HTT | P42858 | 6/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.47 |
| ▸ | TSHR | P16473 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | PKM | P14618 | 3/20 | 0.47 |
| ▸ | XBP1 | P17861 | 3/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 3/20 | 0.45 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | PPARA | Q07869 | 2/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5469248 | 0.85 | CTSK (0.47) | ALDH1A1MAPTATMNPSR1LMNA | |
| SCHEMBL3619257 | 0.85 | CTSK (0.47) | ALDH1A1MAPTATMNPSR1LMNA | |
| SCHEMBL5524483 | 0.84 | CTSK (0.44) | ALDH1A1MAPTATMLMNAHTT | |
| SCHEMBL8283280 | 0.84 | CTSK (0.44) | ALDH1A1MAPTATMLMNAHTT | |
| SCHEMBL5524487 | 0.84 | CTSK (0.44) | ALDH1A1MAPTATMLMNAHTT | |
| SCHEMBL14507999 | 0.84 | CTSK (0.44) | ALDH1A1MAPTATMLMNAHTT | |
| SCHEMBL5529617 | 0.81 | CTSK (0.44) | ALDH1A1MAPTATMLMNAHTT | |
| SCHEMBL5462513 | 0.81 | CTSK (0.44) | ALDH1A1MAPTATMLMNAHTT | |
| SCHEMBL3622543 | 0.81 | CTSK (0.44) | ALDH1A1MAPTATMLMNAHTT | |
| SCHEMBL5945913 | 0.78 | CTSK (0.44) | ALDH1A1MAPTATMLMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3312230-B1 | RUBBER COMPOSITION, LAMINATE, AND CONVEYOR BELT | BRIDGESTONE CORP (JP) | 2020-04-15 | — | — | EP | disclosed |
| EP-3312235-B1 | RUBBER COMPOSITION, LAMINATE, AND CONVEYOR BELT | BRIDGESTONE CORP (JP) | 2019-10-30 | — | — | EP | disclosed |
| EP-3312231-B1 | RUBBER COMPOSITION, LAMINATE, AND CONVEYOR BELT | BRIDGESTONE CORP (JP) | 2019-08-07 | — | — | EP | disclosed |
| EP-3312229-B1 | RUBBER COMPOSITION, LAMINATE, AND CONVEYOR BELT | BRIDGESTONE CORP (JP) | 2019-07-17 | — | — | EP | disclosed |
| US-20190092932-A1 | RUBBER COMPOSITION, LAMINATED BODY, AND CONVEYOR BELT | BRIDGESTONE CORPORATION (JP) | 2019-03-28 | — | — | US | disclosed |
| US-20190055381-A1 | RUBBER COMPOSITION, LAMINATED BODY, AND CONVEYOR BELT | BRIDGESTONE CORPORATION (JP) | 2019-02-21 | — | — | US | disclosed |
| US-20190047790-A1 | RUBBER COMPOSITION, LAMINATED BODY, AND CONVEYOR BELT | BRIDGESTONE CORPORATION (JP) | 2019-02-14 | — | — | US | disclosed |
| EP-3424996-A1 | RUBBER COMPOSITION, LAMINATE, AND CONVEYOR BELT | Bridgestone Corporation (JP) | 2019-01-09 | — | — | EP | disclosed |
| EP-3424997-A1 | RUBBER COMPOSITION, LAMINATE BODY, AND CONVEYER BELT | Bridgestone Corporation (JP) | 2019-01-09 | — | — | EP | disclosed |
| EP-3424998-A1 | RUBBER COMPOSITION, LAMINATE BODY, AND CONVEYER BELT | Bridgestone Corporation (JP) | 2019-01-09 | — | — | EP | disclosed |
| EP-3312230-A1 | RUBBER COMPOSITION, LAMINATE, AND CONVEYOR BELT | Bridgestone Corporation (JP) | 2018-04-25 | — | — | EP | disclosed |
| EP-3312231-A1 | RUBBER COMPOSITION, LAMINATE, AND CONVEYOR BELT | Bridgestone Corporation (JP) | 2018-04-25 | — | — | EP | disclosed |
| CN-1739826-B | Method for manufacturing leather ball piece | TANG YAFANG | 2014-11-19 | — | — | CN | disclosed |
| US-20070049594-A1 | Novel compounds and compositions as cathepsin inhibitors | AVENTIS PHARMACEUTICALS INC. (US) | 2007-03-01 | — | — | US | disclosed |
| US-20070022798-A1 | Method of treating optical film, apparatus of treating optical film, and method of manufacturing optical film | KONICA MINOLTA OPTO, INC. (JP) | 2007-02-01 | — | — | US | disclosed |
| CN-1739826-A | Ball piece of ball for sports | TANG YAFENG (HK) | 2006-03-01 | — | — | CN | disclosed |
| EP-1383748-A2 | NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2004-01-28 | — | — | EP | disclosed |
| US-6485878-B2 | DEVELOPING ELECTROSTATIC LATENT IMAGE ON PHOTORECEPTOR FORMING TONER IMAGE WITH DEVELOPER, TRANSFERRING ONTO IMAGE FORMING MATERIAL, AND FIXING (WITH HEATING AND PRESSURE ROLLERS); HEATING ROLLER COMPRISES METAL CYLINDER WITH ELASTIC COATING | KONICA CORPORATION (JP) | 2002-11-26 | — | — | US | disclosed |
| WO-2002051983-A2 | NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2002-07-04 | — | — | WO | disclosed |
| US-20010031417-A1 | Image forming method | KONICA CORPORATION (JP) | 2001-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070049594-A1 | Novel compounds and compositions as cathepsin inhibitors | CTSS, CTSB, CTSE | ALDH1A1 4046/4885MAPT 2065/4885ATM 3869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.